PremiumCompany AnnouncementsShell Advances Regulated Share Buy-Back Programme With New Repurchases9h ago
PremiumTipRanks NewswireNuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset9h agoAZNNVS
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
PremiumCompany AnnouncementsHSBC Strengthens Board with Appointment of Alison Platt and Remuneration Chair Succession12h ago
PremiumCompany AnnouncementsHSBC Advances Share Buy-Back, Cancels Additional Shares on Hong Kong Exchange22h ago
PremiumCompany AnnouncementsNestlé Names Manuela Bernasconi Group General Counsel as Leanne Geale Retires1d ago